Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 5/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | TP53 | P04637 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2718916 | 0.87 | TSHR (0.47) | SMN1; SMN2ALDH1A1TSHRTP53MAPT | |
| SCHEMBL2720805 | 0.86 | ALDH1A1 (0.50) | MCHR1SMN1; SMN2ALDH1A1GLATSHR | |
| SCHEMBL2718223 | 0.86 | MCHR1 (0.39) | MCHR1PPARGSSTR4CYP3A4CYP2C9 | |
| SCHEMBL2718476 | 0.85 | MCHR1 (0.41) | MCHR1PPARGSSTR4CYP3A4CYP2C9 | |
| SCHEMBL2717431 | 0.84 | MCHR1 (0.41) | MCHR1HPGDPPARGSSTR4CYP3A4 | |
| SCHEMBL2720762 | 0.83 | MCHR1 (0.40) | MCHR1HPGDPPARGSSTR4CYP3A4 | |
| SCHEMBL2720511 | 0.83 | MCHR1 (0.40) | MCHR1HPGDPPARGSSTR4CYP3A4 | |
| SCHEMBL2717750 | 0.83 | MCHR1 (0.40) | MCHR1HPGDPPARGSSTR4CYP3A4 | |
| SCHEMBL2824329 | 0.83 | ALDH1A1 (0.42) | MCHR1SMN1; SMN2ALDH1A1GLATSHR | |
| SCHEMBL2829324 | 0.81 | MCHR1 (0.33) | MCHR1SMN1; SMN2ALDH1A1GLATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110959023-B | Prepreg and carbon fiber-reinforced composite material | 东丽株式会社 | 2022-08-23 | — | — | CN | disclosed |
| CN-110446745-B | Prepreg and carbon fiber reinforced composite material | 东丽株式会社 | 2022-05-13 | — | — | CN | disclosed |
| US-11319420-B2 | Prepreg and carbon fiber reinforced composite material | TORAY INDUSTRIES, INC. (JP) | 2022-05-03 | — | — | US | disclosed |
| US-11208541-B2 | Prepreg and carbon fiber reinforced material | TORAY INDUSTRIES, INC. (JP) | 2021-12-28 | — | — | US | disclosed |
| US-20210115208-A1 | PREPREG AND CARBON FIBER REINFORCED MATERIAL | TORAY INDUSTRIES, INC. (JP) | 2021-04-22 | — | — | US | disclosed |
| US-20210087362-A1 | PREPREG AND CARBON FIBER REINFORCED MATERIAL | TORAY INDUSTRIES, INC. (JP) | 2021-03-25 | — | — | US | disclosed |
| EP-3763774-A1 | PREPREG AND CARBON-FIBER-REINFORCED COMPOSITE MATERIAL | Toray Industries, Inc. (JP) | 2021-01-13 | — | — | EP | disclosed |
| CN-112041380-A | Prepreg and carbon fiber-reinforced composite material | 东丽株式会社 | 2020-12-04 | — | — | CN | disclosed |
| EP-3660081-A1 | PREPREG AND CARBON-FIBER-REINFORCED COMPOSITE MATERIAL | Toray Industries, Inc. (JP) | 2020-06-03 | — | — | EP | disclosed |
| CN-110959023-A | Prepreg and carbon fiber-reinforced composite material | 东丽株式会社 | 2020-04-03 | — | — | CN | disclosed |
| EP-1698625-B1 | EPOXY COMPOUNDS AND CURED EPOXY RESINS OBTAINED BY CURING THE COMPOUNDS | SUMITOMO CHEMICAL CO (JP) | 2012-10-17 | — | — | EP | disclosed |
| US-20100160555-A1 | RESIN COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-24 | — | — | US | disclosed |
| EP-2133380-A1 | RESIN COMPOSITION | Sumitomo Chemical Company, Limited (JP) | 2009-12-16 | — | — | EP | disclosed |
| US-7538166-B2 | Epoxy compounds and cured epoxy resins obtained by curing the compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-05-26 | — | — | US | disclosed |
| US-20090105388-A1 | Epoxy Resin Composition and Cured Epoxy Resin | SUMITOMO CHEMICAL COMPANY, LIMITED | 2009-04-23 | — | — | US | disclosed |
| US-20090054669-A1 | Process For Producing Epoxy Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-2025695-A1 | EPOXY RESIN COMPOSITION AND CURED EPOXY RESIN | Sumitomo Chemical Company, Limited (JP) | 2009-02-18 | — | — | EP | disclosed |
| US-20090018355-A1 | Process for Crystallizing an Epoxy Compound | SUMITOMO CHEMICAL COMPANY, LTD. | 2009-01-15 | — | — | US | disclosed |
| US-20070184280-A1 | Epoxy compounds and cured epoxy resins obtained by curing the compounds | HITACHI, LTD. (JP) | 2007-08-09 | — | — | US | disclosed |
| EP-1698625-A1 | EPOXY COMPOUNDS AND CURED EPOXY RESINS OBTAINED BY CURING THE COMPOUNDS | Sumitomo Chemical Company, Limited (JP) | 2006-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018355-A1 | Process for Crystallizing an Epoxy Compound | PTGER1, NR5A1, TCP1 | MCHR1 1198/4885SMN1; SMN2 3838/4885ALDH1A1 938/4885 |
| US-20090054669-A1 | Process For Producing Epoxy Compound | RER1, AR, CYP1A1 | MCHR1 621/4885SMN1; SMN2 3455/4885ALDH1A1 464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.